1. New York City-based Synergy Pharmaceuticals’ drug Trulance treats chronic idiopathic constipation.
2. The cancer drug Imbruvica may now be used to treat patients with marginal zone lymphoma who require systemic therapy and have received at least one type of lymphoma therapy.
3. Sunovion Pharmaceuticals’ Latuda can now be used to treat schizophrenia in kids aged 13 to 17 years.
4. Teva Pharmaceuticals developed two new asthma inhalers, the AirDuo RespiClick and the ArmonAir RespiClick.
5. Abbott can now label its Assurity MRI pacemaker as MRI-compatible.
6. Minneapolis-based Medtronic developed a noninvasive heart mapping system to detect irregular heart rhythms.
7. Opdivo can now be used to treat urothelial carcinoma — the most common type of bladder cancer.
More articles on supply chain:
This week’s 5 must-reads for supply chain leaders
A new framework for measuring the true value of drugs: 5 takeaways
Bloomberg: Medtronic arranging sale of medical supplies business
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
